| (210) | Number of the EPO application | 18815293 |
| (220) | Filing date of the EPO application | 2018.11.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 01/2022, 2022.01.05 |
| (110) | EPO patent number | 3716952 |
| (11) | Number of the document | MD 3716952 T2 |
| (21) | Number of the application | e 2020 1002 |
| (71) | Name(s) of applicant(s), code of the country | Kalvista Pharmaceuticals Limited, GB; |
| (72) | Name(s) of inventor(s), code of the country | COLLETT John Herman, GB;
COOK Gary Paul, US;
FARRAR Jamie Joseph, GB;
FRODSHAM Michael John, GB;
ROE Michael Bryan, GB;
TODD Richard Simon, GB;
WARD Robert Neil, GB; |
| (73) | Name(s) of owner(s), code of the country | KALVISTA PHARMACEUTICALS LIMITED, GB; |
| (54) | Title of the invention | Dosage forms comprising a plasma kallikrein inhibitor |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/20 (2006.01.01); A61K 9/28 (2006.01.01); A61K 9/48 (2006.01.01); A61K 9/16 (2006.01.01); A61K 31/00 (2006.01.01); A61K 31/444 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2020.10.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.06.30 |
| (30) | Priority | 201762592242 P, 2017.11.29, US; 201721515, 2017.12.21, GB |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/GB2018/053443, 2018.11.28 |
| (87) | International publication | WO 2019/106361, 2019.06.06 |